Log in
Antacid and calcium supplement

Calcium carbonate

Calcium carbonate is an alkaline salt used both as an antacid to neutralize gastric acid and as a calcium supplement to prevent or treat hypocalcemia and osteoporosis. It provides the highest percentage of elemental calcium (40%) among calcium salts, making it the most commonly used oral calcium formulation. The most testable fact is that calcium carbonate requires acid for absorption, so its bioavailability is significantly reduced in achlorhydria or with proton pump inhibitors.

Drug classAntacid and calcium supplement
MechanismNeutralizes gastric acid; provides elemental calcium for supplementation
Main usesGERD, dyspepsia, hypocalcemia, osteoporosis prevention
Key adverse effectConstipation, hypercalcemia with excessive intake
9 min readFor medical studentsUpdated 2026-10-15

Mechanism of action

Calcium carbonate acts through two distinct mechanisms depending on its therapeutic application.

Antacid action

As an antacid, calcium carbonate directly neutralizes hydrochloric acid in the gastric lumen through a simple acid-base reaction: CaCO₃ + 2HCl → CaCl₂ + H₂O + CO₂. This reaction increases gastric pH, providing rapid symptomatic relief from acid-related symptoms. The onset of action is within 3-5 minutes. The neutralization produces carbon dioxide gas, which can cause belching and gastric distension. Calcium carbonate has a higher acid-neutralizing capacity compared to sodium bicarbonate or magnesium hydroxide on a per-gram basis.

Calcium supplementation

When used as a supplement, calcium carbonate provides elemental calcium that is absorbed primarily in the duodenum and proximal jejunum. Absorption requires an acidic environment where calcium carbonate dissolves to release calcium ions. The calcium is then absorbed via both active (vitamin D-dependent, saturable) and passive (concentration-dependent) mechanisms. Active transport predominates at lower calcium intakes and is mediated by vitamin D through increased expression of calcium-binding proteins and calcium channels in enterocytes. Once absorbed, calcium is incorporated into bone, participates in neuromuscular transmission, supports blood coagulation, and serves as a second messenger in numerous cellular processes.

High-yield for exams
  • Calcium carbonate contains 40% elemental calcium, the highest percentage among calcium salt formulations
  • Requires gastric acid for absorption; bioavailability is significantly reduced in achlorhydria or with PPIs
  • Should be taken with food to maximize absorption and minimize gastrointestinal side effects
  • Most common adverse effect is constipation; risk increases with dose
  • Milk-alkali syndrome: hypercalcemia, metabolic alkalosis, and renal insufficiency with excessive intake
  • Chelates fluoroquinolones, tetracyclines, bisphosphonates, levothyroxine, and iron; separate by 2-4 hours
  • Thiazide diuretics reduce urinary calcium excretion, increasing hypercalcemia risk when combined with calcium
  • Dividing daily dose into increments of ≤500 mg elemental calcium maximizes absorption efficiency

Indications

Gastrointestinal conditions

  • Symptomatic relief of heartburn and acid indigestion: rapid-onset relief for occasional gastroesophageal reflux symptoms
  • Dyspepsia: management of upper abdominal discomfort related to gastric hyperacidity
  • Adjunctive therapy in peptic ulcer disease: historically used but largely replaced by proton pump inhibitors and H2 antagonists

Calcium supplementation indications

  • Osteoporosis prevention and treatment: often combined with vitamin D to reduce fracture risk in postmenopausal women and elderly patients
  • Hypocalcemia: treatment and prevention in patients with inadequate dietary calcium intake, hypoparathyroidism, or vitamin D deficiency
  • Chronic kidney disease-mineral and bone disorder: used as a phosphate binder to reduce phosphate absorption in patients with renal failure, though calcium acetate is often preferred for this indication
  • Prevention of pre-eclampsia: supplementation in pregnant women with low dietary calcium intake
  • Osteopenia: prevention of progression to osteoporosis
  • Nutritional support: in conditions associated with increased calcium requirements such as pregnancy, lactation, and growth periods

Off-label uses

  • Hyperphosphatemia: binds dietary phosphate in the gut to reduce serum phosphate levels in chronic kidney disease
  • Colorectal adenoma prevention: some evidence suggests calcium supplementation may reduce recurrence of colorectal adenomas

Pharmacokinetics

Absorption: Calcium carbonate is poorly soluble in neutral or alkaline pH but dissolves readily in gastric acid. Approximately 25-35% of elemental calcium is absorbed from calcium carbonate under optimal conditions, though absorption efficiency decreases as intake increases due to saturation of active transport mechanisms. Peak serum calcium levels occur 3-5 hours after oral administration. Absorption is enhanced when taken with meals because food stimulates gastric acid secretion. Calcium carbonate contains 40% elemental calcium by weight, the highest among calcium salts (compared to 21% for calcium citrate and 9% for calcium gluconate).

Distribution: Absorbed calcium distributes throughout extracellular fluid and rapidly equilibrates with bone calcium stores. Approximately 99% of total body calcium resides in bone and teeth, while 1% is in extracellular fluid and soft tissues. In plasma, about 50% of calcium is ionized (physiologically active), 40% is protein-bound (mainly to albumin), and 10% is complexed with anions like citrate and phosphate.

Metabolism: Calcium carbonate itself is not metabolized. The carbonate component is converted to carbon dioxide and water upon reaction with gastric acid. Calcium homeostasis is tightly regulated by parathyroid hormone, vitamin D, and calcitonin through effects on intestinal absorption, renal excretion, and bone remodeling.

Excretion: Calcium is eliminated primarily via the kidneys (200-300 mg/day under normal conditions) and to a lesser extent in feces (unabsorbed dietary calcium and calcium secreted into the gut). Renal excretion is regulated by parathyroid hormone, which increases calcium reabsorption in the distal tubule. Small amounts are also lost in sweat.

Special populations: Absorption is impaired in achlorhydria, following gastric surgery, in older adults with reduced gastric acid production, and in patients taking acid-suppressing medications. Patients with chronic kidney disease have altered calcium metabolism and require careful monitoring to avoid hypercalcemia.

Adverse effects

Common adverse effects

  • Constipation (10-20% of patients): most frequent adverse effect, dose-related
  • Flatulence and bloating: due to carbon dioxide production from acid neutralization
  • Belching: gas production in the stomach
  • Nausea: especially with high doses

Serious adverse effects

  • Hypercalcemia: risk increases with doses exceeding 2000-2500 mg elemental calcium daily, especially in patients with renal impairment or those taking vitamin D supplements. Symptoms include fatigue, confusion, constipation, polyuria, polydipsia, and in severe cases, cardiac arrhythmias and renal failure
  • Milk-alkali syndrome: rare but serious condition characterized by hypercalcemia, metabolic alkalosis, and renal insufficiency, typically occurring with excessive calcium carbonate intake combined with absorbable alkali
  • Hypophosphatemia: calcium carbonate binds dietary phosphate, potentially causing low serum phosphate with chronic high-dose use
  • Renal calculi: calcium supplementation may increase risk of kidney stones, particularly in susceptible individuals
  • Acid rebound: discontinuation after chronic use as an antacid may cause reactive gastric acid hypersecretion
  • Cardiovascular events: some observational studies have suggested an association between calcium supplementation and increased risk of myocardial infarction, though evidence remains controversial

Gastrointestinal effects

  • Abdominal pain or cramping
  • Dry mouth
  • Early satiety

Metabolic effects

  • Hypercalciuria (increased urinary calcium excretion)
  • Altered absorption of other minerals (iron, zinc, magnesium)

Contraindications and warnings

Absolute contraindications

  • Hypercalcemia: from any cause including hyperparathyroidism, malignancy, sarcoidosis, or vitamin D toxicity
  • Severe renal impairment or renal failure: risk of calcium accumulation and soft tissue calcification
  • History of calcium-containing renal calculi: increased risk of stone recurrence
  • Hypersensitivity: to calcium carbonate or any formulation components

Relative contraindications and warnings

  • Achlorhydria or hypochlorhydria: significantly impairs calcium absorption; calcium citrate is preferred in these patients
  • Chronic kidney disease: requires careful monitoring and dose adjustment to avoid hypercalcemia and vascular calcification
  • Sarcoidosis: patients have increased sensitivity to vitamin D and risk of hypercalcemia
  • Hypoparathyroidism being treated with vitamin D: careful monitoring required to avoid hypercalcemia
  • Constipation-prone patients: may worsen existing constipation

Special populations

Pregnancy: Category C (though generally considered safe). Calcium requirements increase during pregnancy. Adequate calcium intake is important for fetal bone development and may reduce pre-eclampsia risk. Excessive intake should be avoided due to theoretical risk of hypercalcemia.

Lactation: Calcium is excreted in breast milk. Calcium requirements increase during breastfeeding. Supplementation is generally considered safe but should not exceed recommended dietary allowances.

Elderly: Higher risk of achlorhydria, constipation, and polypharmacy-related drug interactions. May require calcium citrate instead for better absorption.

Pediatric: Safe for use in children with appropriate age-based dosing. Growing children and adolescents have increased calcium requirements.

Monitoring recommendations

  • Serum calcium levels in patients receiving chronic high-dose therapy or those with renal impairment
  • Renal function in long-term users
  • Serum phosphate in patients using calcium carbonate as a phosphate binder
  • Symptoms of hypercalcemia (confusion, polyuria, constipation, nausea)

Drug interactions

Medications with reduced absorption

Calcium carbonate chelates or binds numerous medications, reducing their bioavailability. Separate administration by at least 2-4 hours.

  • Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin): calcium forms insoluble complexes, reducing antibiotic absorption by up to 90%
  • Tetracycline antibiotics (doxycycline, tetracycline): chelation significantly reduces absorption of both agents
  • Bisphosphonates (alendronate, risedronate): calcium severely impairs absorption; separate by at least 30-60 minutes
  • Levothyroxine: reduced absorption; separate by at least 4 hours
  • Iron supplements: calcium inhibits iron absorption; separate administration
  • Zinc supplements: competitive inhibition of absorption
  • Quinolones and tetracyclines: formation of non-absorbable chelate complexes

Medications affecting calcium levels

  • Thiazide diuretics: decrease urinary calcium excretion, increasing risk of hypercalcemia when combined with calcium supplementation
  • Loop diuretics (furosemide): increase urinary calcium excretion, potentially necessitating increased supplementation
  • Vitamin D: enhances calcium absorption; combined use requires monitoring for hypercalcemia
  • Calcitriol and other vitamin D analogs: markedly increase calcium absorption and risk of hypercalcemia
  • Cardiac glycosides (digoxin): hypercalcemia increases risk of digoxin toxicity and arrhythmias; use combination cautiously

Acid-suppressing medications

  • Proton pump inhibitors (omeprazole, pantoprazole): reduce calcium carbonate absorption by 40-60% due to increased gastric pH; calcium citrate is preferred
  • H2-receptor antagonists (ranitidine, famotidine): similarly impair absorption though to a lesser extent

Other significant interactions

  • Corticosteroids: decrease calcium absorption and increase urinary excretion; calcium supplementation often necessary
  • Phosphate supplements: calcium binds phosphate, reducing absorption of both
  • Sotalol and other medications with pH-dependent absorption: altered bioavailability
  • Sodium polystyrene sulfonate: risk of metabolic alkalosis when used together
  • Estrogens: may increase calcium absorption and retention

Food interactions

  • High-fiber foods: may reduce calcium absorption
  • Oxalate-rich foods (spinach, rhubarb): form insoluble calcium oxalate, reducing absorption
  • Phytate-rich foods (whole grains, legumes): chelate calcium and reduce absorption

Clinical pearls

  • Elemental calcium content matters: Calcium carbonate provides 40% elemental calcium, so a 1250 mg tablet contains 500 mg of elemental calcium. Always calculate elemental calcium when determining doses or comparing products.
  • Timing with meals: Unlike calcium citrate, calcium carbonate should be taken with food to maximize absorption because gastric acid is required for dissolution. Taking with meals also reduces gastrointestinal side effects.
  • Dose fractionation: Absorption efficiency decreases as single-dose amount increases. Divide daily calcium into doses of 500 mg elemental calcium or less, taken several hours apart, to maximize total absorption.
  • PPI and H2 blocker patients: Patients on chronic acid suppression absorb calcium carbonate poorly. Switch to calcium citrate, which does not require acid for absorption.
  • Vitamin D co-administration: Calcium absorption is optimized when vitamin D status is adequate. Many calcium supplements are formulated with vitamin D for this reason. Check vitamin D levels in patients with suspected malabsorption.
  • Milk-alkali syndrome recognition: This triad of hypercalcemia, metabolic alkalosis, and renal impairment is often missed. Suspect in patients taking high-dose calcium carbonate, especially if combined with dairy products or other alkali sources.
  • Constipation management: Starting with lower doses and gradually increasing, ensuring adequate hydration, and combining with magnesium-containing supplements can help mitigate constipation.
  • Cardiovascular controversy: While some studies suggest increased cardiovascular risk with calcium supplementation, current guidelines support its use when dietary intake is inadequate. Dietary calcium is preferred over supplementation when possible.
  • Renal stone formers: Not all patients with kidney stones need to avoid calcium. Low dietary calcium can actually increase stone risk by allowing increased oxalate absorption. However, supplemental calcium should be used cautiously and preferably with meals.
  • Drug interaction management: The 2-4 hour separation rule is critical. Create a medication schedule that spaces calcium away from interacting drugs. Morning levothyroxine should be separated from calcium taken with breakfast.
  • Phosphate binding in CKD: When used as a phosphate binder in dialysis patients, calcium carbonate must be taken with meals to bind dietary phosphate. However, calcium-based binders can contribute to vascular calcification, so newer non-calcium binders are increasingly preferred.
  • Laboratory considerations: Correct serum calcium for albumin level using the formula: corrected calcium = measured calcium + 0.8 × (4.0 - serum albumin). Ionized calcium measurement is more accurate when albumin is abnormal.
  • Comparison with calcium citrate: Calcium citrate is better absorbed in achlorhydria, causes less constipation, and can be taken without food, but provides less elemental calcium per tablet (21% vs 40%) and is more expensive.

Practice questions

1. A 72-year-old woman with osteoporosis has been taking omeprazole 40 mg daily for gastroesophageal reflux disease for 3 years. She was started on calcium carbonate 1250 mg (500 mg elemental calcium) twice daily with meals. At her follow-up visit 6 months later, her bone density scan shows continued bone loss despite reported medication adherence. Her serum calcium is 9.1 mg/dL (normal 8.5-10.5). Which of the following best explains the inadequate response?

Answer: B. Calcium carbonate requires an acidic environment to dissolve and be absorbed. Omeprazole, a proton pump inhibitor, markedly increases gastric pH and reduces calcium carbonate absorption by 40-60%. This patient should be switched to calcium citrate, which does not require acid for absorption. Taking calcium carbonate with food is correct (option D is wrong). While vitamin D deficiency can impair absorption, the question stem provides no evidence for this, and the primary issue is the drug interaction with omeprazole.

2. A 45-year-old man with chronic kidney disease stage 4 presents with fatigue and diffuse bone pain. Laboratory studies show: calcium 11.8 mg/dL (normal 8.5-10.5), phosphate 7.2 mg/dL (normal 2.5-4.5), PTH 450 pg/mL (normal 10-65), and creatinine 3.8 mg/dL. He has been taking calcium carbonate 1500 mg three times daily as a phosphate binder. Which of the following is the most appropriate next step?

Answer: C. This patient has hypercalcemia (11.8 mg/dL) from excessive calcium carbonate intake as a phosphate binder, despite hyperphosphatemia and secondary hyperparathyroidism. Continuing or increasing calcium-based binders risks worsening hypercalcemia and promoting vascular calcification in CKD. The appropriate management is to switch to a non-calcium phosphate binder such as sevelamer or lanthanum. Adding calcitriol would worsen hypercalcemia. Thiazides would also worsen hypercalcemia by reducing urinary calcium excretion. Parathyroidectomy is premature before optimizing medical management.

3. A 58-year-old woman presents to the emergency department with confusion, severe constipation, and polyuria. She has been self-treating chronic indigestion with over-the-counter calcium carbonate tablets, consuming approximately 15-20 tablets daily for the past 2 months. She also drinks 4-5 glasses of milk daily. Laboratory results show: calcium 13.2 mg/dL, bicarbonate 32 mEq/L, creatinine 2.1 mg/dL (baseline 0.9), and normal PTH. Which of the following is the most likely diagnosis?

Answer: C. This patient has the classic triad of milk-alkali syndrome: hypercalcemia (13.2 mg/dL), metabolic alkalosis (bicarbonate 32 mEq/L), and acute kidney injury (creatinine 2.1 from 0.9), caused by excessive calcium carbonate intake combined with high dairy consumption. The normal PTH excludes primary hyperparathyroidism. The clinical history of massive antacid use and milk consumption is pathognomonic for milk-alkali syndrome. Malignancy-related hypercalcemia would typically present with suppressed PTH but without the metabolic alkalosis and would have other signs of malignancy. Sarcoidosis and vitamin D toxicity would show elevated 1,25-dihydroxyvitamin D levels.

Frequently asked questions

How does calcium carbonate work as an antacid?

Calcium carbonate neutralizes gastric acid through a direct chemical reaction: CaCO₃ + 2HCl → CaCl₂ + H₂O + CO₂. This acid-base reaction raises gastric pH within 3-5 minutes, providing rapid symptomatic relief from heartburn and acid indigestion. The reaction produces carbon dioxide gas, which causes belching. Calcium carbonate has a high acid-neutralizing capacity compared to other antacids.

What are the side effects of calcium carbonate?

The most common side effect is constipation, occurring in 10-20% of patients. Other frequent effects include bloating, flatulence, and belching due to carbon dioxide production. Serious adverse effects with excessive intake include hypercalcemia (elevated blood calcium causing confusion, kidney problems, cardiac arrhythmias), milk-alkali syndrome (hypercalcemia with metabolic alkalosis and renal impairment), and increased risk of kidney stones. Hypophosphatemia can occur with chronic high-dose use.

Should calcium carbonate be taken with or without food?

Calcium carbonate should be taken with food for optimal absorption. Unlike calcium citrate, calcium carbonate requires an acidic environment to dissolve and release calcium ions for absorption. Taking it with meals stimulates gastric acid secretion, enhancing dissolution and absorption. Additionally, taking calcium carbonate with food reduces gastrointestinal side effects like bloating and nausea. Patients on acid-suppressing medications should use calcium citrate instead.

Can I take calcium carbonate with other medications?

Calcium carbonate interacts with many medications by forming insoluble complexes that reduce drug absorption. It significantly impairs absorption of fluoroquinolones, tetracyclines, bisphosphonates, levothyroxine, and iron supplements. Separate calcium carbonate from these medications by at least 2-4 hours. Thiazide diuretics combined with calcium increase hypercalcemia risk. Proton pump inhibitors reduce calcium carbonate absorption by 40-60%; switch to calcium citrate if on chronic acid suppression. Always review your medication list with your healthcare provider.

What is the difference between calcium carbonate and calcium citrate?

Calcium carbonate contains 40% elemental calcium versus 21% for calcium citrate, requiring fewer tablets for the same calcium dose. However, calcium carbonate requires stomach acid for absorption and must be taken with food, while calcium citrate is absorbed independently of gastric pH and can be taken anytime. Calcium citrate is preferred for patients with achlorhydria, those taking acid-suppressing medications, or elderly individuals with reduced acid production. Calcium carbonate causes more constipation but is less expensive than calcium citrate.

Conditions it is used for

Gastroesophageal reflux diseaseDyspepsiaHeartburnOsteoporosisOsteopeniaHypocalcemiaHyperphosphatemiaHypoparathyroidism
calcium citratecalcium acetatecalcium gluconatevitamin Dcholecalciferolalendronateomeprazolesevelamer

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A02AC01WHO ATC/DDD index: A12AA04

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.